Universal Diagnostics

universaldx.com

Universal Diagnostics (UDX) is a bioinformatics and multi-omics company focused on early cancer detection through blood tests. Their flagship product, Signal C®, is a liquid biopsy test that accurately detects colorectal cancer with a sensitivity of 92% and specificity of 94%. UDX employs a multi-omics and machine learning approach to identify cancer signals, aiming to transform cancer into a preventable and curable disease. With strategic collaborations, including one with Quest Diagnostics, UDX is positioned to significantly impact cancer screening and treatment outcomes, leveraging a network of over 100 hospitals and clinical teams across the U.S. and Europe.